The use of intravenous vitamin C in hospitals, pre and post-surgery and for respiratory infections.
Intravenous Vitamin C (IVC) has shown promising potential in enhancing recovery outcomes for patients undergoing surgery and those suffering from respiratory infections. One of the primary reasons hospitals should consider administering IVC pre- and post-surgery is its ability to support the immune system and accelerate tissue repair.
Vitamin C is a potent antioxidant, helping to neutralise harmful free radicals that can be generated during surgical procedures. Pre-surgery administration may reduce oxidative stress, inflammation, and tissue damage, potentially improve wound healing and decrease the risk of postoperative complications, such as infection. Additionally, Vitamin C plays a crucial role in collagen synthesis, which is vital for tissue regeneration, making it especially important in the recovery phase following surgery.
In the context of respiratory infections, IVC has demonstrated the ability to reduce the severity and duration of symptoms. Vitamin C is known to enhance the immune response, particularly in the defense against viral and bacterial pathogens.
For patients with conditions like pneumonia or severe colds, high-dose intravenous Vitamin C has been shown to reduce inflammation in the lungs, improve oxygenation, and lower the risk of further complications. Moreover, IVC can support the function of white blood cells, which are essential for fighting infections, and can provide antioxidant protection to lung tissues, which are often exposed to high levels of oxidative stress during infection. Hospitals utilising IVC in these scenarios could lead to faster recovery times, lower rates of complications, and improved overall patient outcomes.